Generali Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$76.5M Buy
63,771
+1,120
+2% +$1.14M 1.38% 15
2026
Q1
$57.6M Sell
62,651
-4,057
-6% -$4.11M 1.2% 16
2025
Q4
$71.7M Buy
66,708
+5,416
+9% +$5.18M 1.47% 13
2025
Q3
$46.8M Sell
61,292
-6,430
-9% -$4.78M 1% 18
2025
Q2
$52.8M Sell
67,722
-2,947
-4% -$2.29M 1.2% 14
2025
Q1
$58.4M Sell
70,669
-454
-0.6% -$378K 1.44% 12
2024
Q4
$54.9M Buy
+71,123
New +$58.9M 1.4% 10

Other funds holding LLY

Generali Asset Management's LLY Position: Q2 2026 in Review

Generali Asset Management increased its Eli Lilly (LLY) stake by 1.8% in Q2 2026, buying an estimated $1.14M and bringing the position to 63,771 shares worth $76.5M. The position accounts for 1.38% of the portfolio, ranked #15.

Generali Asset Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 2,115 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Generali Asset Management held 63,771 shares of Eli Lilly worth $76.5M as of Q2 2026.
  • Generali Asset Management bought 1,120 Eli Lilly shares in Q2 2026, an estimated $1.14M.
  • Eli Lilly made up 1.38% of Generali Asset Management's portfolio in Q2 2026, its #15 holding.
  • Generali Asset Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 2,115 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.